Nexplanon 68 MG implants
Ended Awarded
- Contract number
- SPE2DB25FK91S
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $34,716
Award facts
- Contract value 100% obligated
- $34,715.50 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Park Ridge, IL 60068, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a $34,715.50 firm fixed-price delivery order to DMS Pharmaceutical Group Inc. for Nexplanon 68 mg implants, with an ultimate completion date of August 22, 2025. DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was selected without a set-aside designation. The delivery order represents pharmaceutical supplies to support Department of Defense healthcare operations and falls under the company's larger Indefinite Delivery Contract with the DLA under the SPE2DB program, valued at $499,999,999 and valid through November 2026.
DMS Pharmaceutical Group has established itself as a significant supplier in the federal pharmaceutical supply chain, consistently securing contracts with the Defense Logistics Agency for an extensive portfolio of medical products spanning prescription medications, biologics, vaccines, and specialty pharmaceutical items. Nexplanon implants, a subdermal contraceptive device, exemplify the company's role in delivering critical medical supplies to military healthcare facilities nationwide. The firm fixed-price structure and delivery order mechanism reflect the efficiency of the IDC vehicle in enabling the government to procure pharmaceutical products rapidly to meet healthcare demands across Department of Defense medical installations globally.
Quick answers
Who was awarded contract SPE2DB25FK91S?
SPE2DB25FK91S was awarded to DMS Pharmaceutical Group Inc. by Defense Logistics Agency (Department of Defense) on August 1, 2025.
How much is contract SPE2DB25FK91S worth?
The government has obligated $34,716 on SPE2DB25FK91S.
Is contract SPE2DB25FK91S an order under another contract?
Yes. SPE2DB25FK91S is a delivery order under SPE2DB20D9202, an indefinite delivery contract.
Was contract SPE2DB25FK91S competed?
The extent of competition for SPE2DB25FK91S was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award